ACQUISITIONS - Schedule of identifiable assets acquired and liabilities assumed (Details) - USD ($) $ in Thousands |
Sep. 30, 2022 |
Apr. 30, 2022 |
Dec. 31, 2021 |
Sep. 30, 2021 |
Dec. 31, 2020 |
---|---|---|---|---|---|
Business Combination, Separately Recognized Transactions [Line Items] | |||||
Goodwill | $ 8,079 | $ 2,068 | $ 2,068 | $ 2,068 | |
Kind Therapeutics USA LLC. | |||||
Business Combination, Separately Recognized Transactions [Line Items] | |||||
Current assets, net of cash acquired | $ 5,047 | ||||
Property and equipment | 622 | ||||
Goodwill | 6,011 | ||||
Current liabilities | (511) | ||||
Fair value of net assets acquired | 17,952 | ||||
Kind Therapeutics USA LLC. | Tradename and trademarks | |||||
Business Combination, Separately Recognized Transactions [Line Items] | |||||
Intangible assets: | 2,041 | ||||
Kind Therapeutics USA LLC. | Licenses and customer base | |||||
Business Combination, Separately Recognized Transactions [Line Items] | |||||
Intangible assets: | 4,700 | ||||
Kind Therapeutics USA LLC. | Non-compete agreements | |||||
Business Combination, Separately Recognized Transactions [Line Items] | |||||
Intangible assets: | $ 42 |
X | ||||||||||
- Definition Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of intangible assets, excluding goodwill, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of property, plant, and equipment recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|